Project: Cytomegalovirus Infections in Hematopoietic Stem Cell Transplantation
The main goal is to characterize Cytomegalovirus (CMV) infection in Hematopoietic Stem Cell Transplantation: 1) Characterize the prevalence of infection; 2) Characterize viral strains; 3) Develop better CMV-monitoring approaches based on laboratory and clinical data;
REFERENCES:
Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art.
Campos AB, Ribeiro J, Boutolleau D, Sousa H.
Rev Med Virol. 2016 May;26(3):161-82. doi: 10.1002/rmv.1873.
Cytomegalovirus infection in patients who underwent allogeneic hematopoietic stem cell transplantation in Portugal: a five-year retrospective review.
Sousa H, Boutolleau D, Ribeiro J, Teixeira AL, Pinho Vaz C, Campilho F, Branca R, Campos A Jr, Baldaque I, Medeiros R.
Biol Blood Marrow Transplant. 2014 Dec;20(12):1958-67. doi: 10.1016/j.bbmt.2014.08.010. Epub 2014 Aug 17.
PMID: 25139217